You want results not lazy guidelines and best practices and care.
Big fucking whoopee.
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=226354#.WU8vZ-kpCM8
PR Newswire
BEIJING, June 24, 2017
BEIJING, June 24, 2017 /PRNewswire/ -- Delivering big,
positive stroke outcomes for the world's largest population is the aim
of the American Stroke Association (ASA) and Chinese Stroke Association
(CSA) with the launch of a quality improvement program adapted from the
American Heart Association's guidelines-based program called Get With
The Guidelines®.
The program works to improve treatment for, and prevention
of, cardiovascular and stroke events by helping hospitals and providers
consistently adhere to the latest scientific treatment guidelines. In
the last 15 years, Get With The Guidelines has transformed patient care
for heart and stroke patients in the U.S., helping hospitals and
providers learn the correct treatment and translate guidelines into
practice. This program has saved lives and resulted in more than 400
scientific publications that advance heart and brain health around the
world.
The adapted Get With The Guidelines program, designed through
a collaboration of the ASA and the CSA, endorsed by the China National
Health and Family Planning Commission, and supported by Medtronic, is a
set of "best practices" that aim to continuously improve treatment,
enhance the quality of care, and prevent future stroke events in China.
While several evidence-based, highly effective,
guideline-recommended therapies are known, adherence to guidelines for
stroke care remains incomplete and highly variable from region to
region, and country to country.
This effort aims to solve for that in China. Specifically, this program addresses the need for:
1. Enhanced education for EMS and pre-hospital
caregivers, especially since analysis shows only 13 percent of Chinese
stroke patients arrive at the hospital by EMS, versus 50 percent in the
U.S.
2. A reduction in "door-to-needle" times for patients to
receive the clot-busting drug tPA. To-date, analysis for rates of
compliance with evidenced based therapies notes significant gaps in
timeliness to tPA treatment.
3. Increased awareness and application of mechanical endovascular reperfusion therapies in appropriate patients.
4. Increased awareness and application of secondary prevention in appropriate stroke patients to fill significant gaps in venous thromboembolism (VTE) prophylaxis, lipid lowering therapy, anticoagulation for atrial fibrillation and rehabilitation assessment in Chinese patients.
With a population of 1.4 billion, stroke is the leading
killer and claims the lives of 1.6 million Chinese people annually.
Today, China faces cardiovascular and stroke risk factors similar to
those in Western nations. Among risk factors, hypertension remains the
most important for all types of strokes.[1] Additionally, the concept of
a "stroke belt" in China has emerged which identifies specific
geographic regions where the mortality associated with stroke is 50
percent higher than that of other regions in the country. Currently, the
areas with higher mortality are the northeast and the
western/southwestern.[2]
In 2007, the Ministry of Health -- now National Health and
Family Planning Commission -- sponsored the Chinese National Stroke
Registry and a five-year plan to increase comprehensive stroke centers
in China. Establishing the registry also led to creating the Stroke
Screening, Prevention and Treatment Project in 2009, and more recently
the National Center of Stroke Care Quality Control in 2011.
"The American Stroke Association is deeply committed to
having a transformative impact on healthcare systems and patients
worldwide by working alongside countries, governments and international
cardiovascular and cerebrovascular societies to facilitate the
application of the tools and knowledge of our quality programs," said
Ying Xian, M.D., Ph.D, American Stroke Association spokesperson and
Assistant Professor of Neurology and Medicine at the Duke University
Medical Center and Duke Clinical Research Institute. "The U.S.
marketplace has given us a road map to develop scalable and sustainable
models for international quality improvement initiatives. Now, with our
consult, the Chinese Stroke Association aims to adopt those models to
achieve better outcomes for stroke patients in China."
"It is with great excitement that we announce the launch of
this collaborative stroke quality improvement project between the CSA
and ASA to further enhance cooperation on clinical research, education,
and the impact of acute stroke science," said Jizong Zhao, President,
CSA. "I congratulate both organizations' dedication to improving stroke
outcomes in China."
Reaching healthcare providers with the Get With The
Guidelines program at Chinese secondary and tertiary hospitals -- and at
all stages of the chain of survival, from pre-hospital advanced medical
care (also known as EMS or emergency medical services) to neurologists
to even hospital administrators -- is the priority.
"Medtronic is a leading stroke care solution provider in
stent retriever therapy with more than 20 years of experience in China.
We provide clinical education and training systems for Chinese
physicians and, together with medical societies, we consistently promote
a hierarchical treatment system, raise public awareness, and speed up
patient admission and treatment to ensure the proper care for patients,"
said Chris Lee, President, Medtronic Greater China. "We are very proud
to collaborate with both the CSA and ASA, and we will continuously work
together to improve China's stroke care quality."
Stroke has also had a significant impact on healthcare
expenditures and the Chinese economy. The cost for stroke care by the
government-funded hospitals was 1.17 billion RMB (approx. $170M USD) in
2003 and 8.19 billion RMB (approx. $1.3B USD) in 2009, a 117 percent
increase annually. Now, the annual cost of stroke care in China is
approximately 40 billion RMB ($5.8B USD).[3]
[1] http://stroke.ahajournals.org/content/42/12/3651
[2] http://stroke.ahajournals.org/content/strokeaha/44/7/1775.full.pdf
[3] http://stroke.ahajournals.org/content/42/12/3651
No comments:
Post a Comment